196 related articles for article (PubMed ID: 17827007)
61. Synthesis and cytotoxic activity of pyrazino[1,2-b]-isoquinolines, 1-(3-isoquinolyl)isoquinolines, and 6,15-iminoisoquino[3,2-b]-3-benzazocines.
González JF; de la Cuesta E; Avendaño C
Bioorg Med Chem; 2007 Jan; 15(1):112-8. PubMed ID: 17070059
[TBL] [Abstract][Full Text] [Related]
62. Structure-based design, synthesis, and biological studies of new anticancer norindenoisoquinoline topoisomerase I inhibitors.
Song Y; Shao Z; Dexheimer TS; Scher ES; Pommier Y; Cushman M
J Med Chem; 2010 Mar; 53(5):1979-89. PubMed ID: 20155916
[TBL] [Abstract][Full Text] [Related]
63. Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship.
Abdel-Aziz M; Matsuda K; Otsuka M; Uyeda M; Okawara T; Suzuki K
Bioorg Med Chem Lett; 2004 Apr; 14(7):1669-72. PubMed ID: 15026047
[TBL] [Abstract][Full Text] [Related]
64. Nitrated indenoisoquinolines as topoisomerase I inhibitors: a systematic study and optimization.
Morrell A; Placzek M; Parmley S; Antony S; Dexheimer TS; Pommier Y; Cushman M
J Med Chem; 2007 Sep; 50(18):4419-30. PubMed ID: 17696418
[TBL] [Abstract][Full Text] [Related]
65. Hydrophilic camptothecin analogs that form extremely stable cleavable complexes with DNA and topoisomerase I.
Wadkins RM; Bearss D; Manikumar G; Wani MC; Wall ME; Von Hoff DD
Cancer Res; 2004 Sep; 64(18):6679-83. PubMed ID: 15374984
[TBL] [Abstract][Full Text] [Related]
66. Synthesis and biological evaluation of pyrroloiminoquinone derivatives.
Passarella D; Belinghieri F; Scarpellini M; Pratesi G; Zunino F; Gia OM; Via LD; Santoro G; Danieli B
Bioorg Med Chem; 2008 Mar; 16(5):2431-8. PubMed ID: 18077173
[TBL] [Abstract][Full Text] [Related]
67. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity.
Choi SJ; Park HJ; Lee SK; Kim SW; Han G; Choo HY
Bioorg Med Chem; 2006 Feb; 14(4):1229-35. PubMed ID: 16242334
[TBL] [Abstract][Full Text] [Related]
68. Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.
You QD; Li ZY; Huang CH; Yang Q; Wang XJ; Guo QL; Chen XG; He XG; Li TK; Chern JW
J Med Chem; 2009 Sep; 52(18):5649-61. PubMed ID: 19715319
[TBL] [Abstract][Full Text] [Related]
69. Synthesis and cytotoxic activity of substituted luotonin A derivatives.
Dallavalle S; Merlini L; Beretta GL; Tinelli S; Zunino F
Bioorg Med Chem Lett; 2004 Dec; 14(23):5757-61. PubMed ID: 15501036
[TBL] [Abstract][Full Text] [Related]
70. Oligopyrrole carboxamides linked with a nucleobase as potential DNA minor groove binding ligands: synthesis, DNA binding and biological evaluation.
Keuser C; Pindur U
Pharmazie; 2006 Apr; 61(4):261-8. PubMed ID: 16649534
[TBL] [Abstract][Full Text] [Related]
71. Indeno[1,2-c]isoquinolines as enhancing agents on all-trans retinoic acid-mediated differentiation of human myeloid leukemia cells.
Kim SH; Oh SM; Song JH; Cho D; Le QM; Lee SH; Cho WJ; Kim TS
Bioorg Med Chem; 2008 Feb; 16(3):1125-32. PubMed ID: 18024133
[TBL] [Abstract][Full Text] [Related]
72. New one-pot synthesis of N-fused isoquinoline derivatives by palladium-catalyzed C-H arylation: potent inhibitors of nucleotide pyrophosphatase-1 and -3.
Ausekle E; Ejaz SA; Khan SU; Ehlers P; Villinger A; Lecka J; Sévigny J; Iqbal J; Langer P
Org Biomol Chem; 2016 Dec; 14(48):11402-11414. PubMed ID: 27858054
[TBL] [Abstract][Full Text] [Related]
73. Topoisomerase I and II inhibitory constituents from the bark of Tilia amurensis.
Choi JY; Seo CS; Zheng MS; Lee CS; Son JK
Arch Pharm Res; 2008 Nov; 31(11):1413-8. PubMed ID: 19023537
[TBL] [Abstract][Full Text] [Related]
74. QSAR studies about cytotoxicity of benzophenazines with dual inhibition toward both topoisomerases I and II: 3D-MoRSE descriptors and statistical considerations about variable selection.
Saíz-Urra L; González MP; Teijeira M
Bioorg Med Chem; 2006 Nov; 14(21):7347-58. PubMed ID: 16962784
[TBL] [Abstract][Full Text] [Related]
75. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure-activity relationship of 9-anilinothiazolo[5,4-b]quinoline derivatives.
Loza-Mejía MA; Olvera-Vázquez S; Maldonado-Hernández K; Guadarrama-Salgado T; González-Sánchez I; Rodríguez-Hernández F; Solano JD; Rodríguez-Sotres R; Lira-Rocha A
Bioorg Med Chem; 2009 May; 17(9):3266-77. PubMed ID: 19364657
[TBL] [Abstract][Full Text] [Related]
76. [Interaction of topotecan--a DNA topoisomerase inhibitor--with dual-stranded polydeoxyribonucleotides. I. Dimerization of topotecan in solution].
Strel'tsov SA; Grokhovskiĭ SL; Kudelina IA; Oleĭnikov VA; Zhuze AL
Mol Biol (Mosk); 2001; 35(3):432-41. PubMed ID: 11443925
[TBL] [Abstract][Full Text] [Related]
77. Synthesis and antitumor evaluation of a novel class of 4-substituted-1,4-dihydroisoquinolin-3-ones.
Ma T; Chen W; Zhang G; Yu Y
J Comb Chem; 2010 Jul; 12(4):488-90. PubMed ID: 20426396
[TBL] [Abstract][Full Text] [Related]
78. Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines.
Xiao X; Miao ZH; Antony S; Pommier Y; Cushman M
Bioorg Med Chem Lett; 2005 Jun; 15(11):2795-8. PubMed ID: 15911256
[TBL] [Abstract][Full Text] [Related]
79. Modification of the antibiotic olivomycin I at the 2'-keto group of the side chain. Novel derivatives, antitumor and topoisomerase I-poisoning activity.
Tevyashova AN; Olsufyeva EN; Balzarini J; Shtil AA; Dezhenkova LG; Bukhman VM; Zbarsky VB; Preobrazhenskaya MN
J Antibiot (Tokyo); 2009 Jan; 62(1):37-41. PubMed ID: 19132061
[TBL] [Abstract][Full Text] [Related]
80. Synthesis and evaluation of indenoisoquinoline topoisomerase I inhibitors substituted with nitrogen heterocycles.
Nagarajan M; Morrell A; Ioanoviciu A; Antony S; Kohlhagen G; Agama K; Hollingshead M; Pommier Y; Cushman M
J Med Chem; 2006 Oct; 49(21):6283-9. PubMed ID: 17034134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]